Top-10 Producer Offers $150M for Nevada Gold Property
Source: Streetwise Reports  (9/19/22)
Coeur Mining Inc. shares traded 18% higher after the company reported it has agreed to sell its Southern Nevada Holdings to AngloGold Ashanti Ltd. for $150 million in cash. The purchase by AngloGold includes provisions for an additional payment of $50 million if the project is shown to host a total resource of 3.5 million ounces of gold or higher. More >

Second Trial of New Eczema Drug To Commence in Q4/22
Source: Dr. Yi Chen  (9/17/22)
The purpose behind this complementary study is to potentially expand the treatment's target patient population, noted an H.C. Wainwright & Co. report. More >

Silver Explorer Expands Golden Triangle Drilling Campaign
Source: Streetwise Reports  (9/16/22)
Dolly Varden Silver Corp. is adding a fourth diamond drilling rig to its campaign at its Kitsault Valley project in British Columbia after seeing big returns. More >

Tech Co. Ready To Advance in a New Bull Market
Source: Clive Maund  (9/16/22)
Expert Clive Maund reviews Danavation Technologies Corp. after the completion of a large base pattern to see whether he believes it is a Buy. More >

Junior Closes on Deal for Critical Metals, Minerals Project
Source: Streetwise Reports  (9/16/22)
Copper and other critical metals and minerals are the backbone of the world's switch to green energy, and Rover Metals Corp. hopes to supply some of them. More >

FDA Grants Approval for Drug Improving Kidney Function
Source: Streetwise Reports  (9/16/22)
Shares of Mallinckrodt Plc. traded 28% higher yesterday after the company reported that the U.S. FDA has issued approval for its Terlivaz® (terlipressin) for injection for use in treating hepatorenal syndrome, a serious and life-threatening condition that is accompanied by rapid reduction in kidney function. More >

Bowling Center's Shares Score New 52-Week High
Source: Streetwise Reports  (9/16/22)
Shares of bowling center operator Bowlero Corp. traded 7.5% higher and rolled to a new 52-week high after the company reported Q4/22 and FY/22 financial results that included a 130.7% YoY increase in annual revenue. More >

Price Target on US Biopharma Co. Boosted by $15
Source: Julian Harrison  (9/15/22)
The increase came after positive clinical trial results on one of its lead drug candidates differentiating it from a competitor, noted a BTIG report. More >

New Drug Shown To Help Patients With Desmoid Tumors
Source: Dr. David Nierengarten  (9/15/22)
This oral gamma-secretase inhibitor met the primary and secondary endpoints in a Phase 3 clinical trial, noted a Wedbush report. More >

Three-Part Approach to Advancing Gold Project Gets Results
Source: Mike Niehuser   (9/15/22)
The explorer recently hit upon the main deposit's feeder zone, discovered a new vein nearby and keeps drilling high-grade gold intercepts, noted a ROTH Capital Partners report. More >

Publishing Co. Rated an 'Interesting Speculative Play'
Source: Clive Maund  (9/15/22)
After a relatively big buyer appeared a week ago and bought a lot of stock from Legible Inc., expert Clive Maund believes something may be on the horizon for the publishing company. More >

NDA for Dry Eye Disease Drug on Track for Q4/22 Submission
Source: Justin Kim   (9/15/22)
This and the biopharma's other treatment candidates for ocular diseases are underappreciated, which translates to an investment opportunity, noted an Oppenheimer report. More >

Several Trials of Co.'s Fluid Pump To Read Out This Year
Source: Dr. Yi Chen  (9/14/22)
Positive topline data could boost the share price of this Swiss medical device firm, noted an H.C. Wainwright & Co. report. More >

Analyst Says Mining Junior Well Positioned To Ride Out Gold Bear Market
Source: Felix Shafigullin  (9/14/22)
The company has numerous elements working in its favor, including a fully permitted gold project only 12 months away from initial production, noted an Eight Capital report. More >

Copper Junior Sees 'Beautiful' Drilling Results in Mexico
Source: Streetwise Reports  (9/14/22)
Infinitum Copper Corp. hopes to help close a coming copper shortage with the red metal coming out of its La Adelita project in Mexico. More >

Oil & Gas Producer Sees 145% Rise in FY22 Production
Source: Streetwise Reports  (9/14/22)
Shares of Evolution Petroleum Corp. traded 19% higher after the U.S. onshore oil and gas producer reported that during FY/22 it increased production by 145% YoY and achieved a 233% increase in annual revenue. The company advised that it is raising its quarterly cash dividend by 20% and is initiating a $25 million share buyback program. More >

Co. Advancing Drug Class With Broad Potential
Source: Dr. Thomas Shrader   (9/13/22)
This developer of C1q-targeting therapeutics, with a catalyst-rich 18 months ahead, warrants analyst coverage, noted a BTIG report. More >

Rare Earths Co. Reaches Important Milestone Before PFS
Source: Mark Reichman  (9/13/22)
The explorer agreed to work together with a local First Nations community as it advances its critical elements project in British Columbia, noted a Noble Capital Markets report. More >

Biotech Co.'s Target Six Times Current Price
Source: Francois Brisebois  (9/13/22)
One Phase 2 clinical trial showing LSD reduced symptoms of anxiety bodes well for other studies of LSD in this indication. In light of this, Oppenheimer & Co. gave this biotech company a target price that is over six times its current share price. More >

Expert Says Life Science Co.'s Technical Setup Is 'Exceptionally Positive and Keeps Getting Better'
Source: Clive Maund  (9/13/22)
Expert Clive Maund reviews the 6-month and 15-month charts for Awakn Life Sciences Corp. to explain why he thinks this company's technical setup is exceptionally positive. More >

Hycroft Reports High Gold and Silver Grades at Nevada Mine
Source: Streetwise Reports  (9/13/22)
Shares of Hycroft Mining Holding Corp. traded 12% higher after the Nevada gold and silver mining firm reported initial drill results from its Hycroft Mine. The company commented that it has encountered multiple zones of continuous higher-grade silver that extend further than prior interpretations.
More >

Healthcare Co.'s To Develop Fast-Dissolving MDMA Tablet
Source: Streetwise Reports  (9/12/22)
One biopharma co. is teaming with a much larger pharmaceutical company to develop a fast-dissolving oral tablet to deliver MDMA to patients with Alcohol Use Disorder. Find out why developing an oral tablet could benefit the company in the long run. More >

Analyst Says Biopharma's New Inhaled Antifungal Drug Shows Promise
Source: Dr. Jonathan Aschoff  (9/12/22)
Trial results are expected later this month, but anecdotal data available now suggest the findings should be positive, noted a ROTH Capital Partners report. More >

Explorer Posts More Good Drill Results at Iberian Belt Property
Source: Adam Schatzker  (9/12/22)
Emerita Resources Corp. reported drill results from five new holes at its Iberian Belt West Project in Spain. Research Capital Corp. commented in a research note that Emerita is proceeding with its aggressive 2022 drill program and expects to resume around-the-clock drilling within the next two weeks. The research firm stated it is maintaining its Speculative Buy rating on the company. More >

Rare Earths Explorer Enters Agreement With Native Group
Source: Streetwise Reports  (9/12/22)
Defense Metals Corp., which hopes to compete with China in the production of vital rare earth elements, has entered into an agreement with the McLeod Lake Indian Band in British Columbia. More >